ACE and hydrops fetalis: [27] Self-reported barriers to HF care by generalists (eg. confidence levels, co-management with cardiologists, fear of adverse reactions) were not correlated with prescribing angiotensin converting enzyme inhibitors (ACE-I) in HF, but may be related to prescribing beta-blockers. [28]–[30]